Effectively Communicating with Patients about Opioid Therapy

This is the seventh webinar in a COCA Call series about CDC Guideline for Prescribing Opioids for Chronic Pain. To view a list of other webinars in the series, visit the opioid call series overview webpage

Date:Tuesday, December 13, 2016

Time: 2:00-3:00 pm (Eastern Time)

Presenter(s)

Overview

Effective communication between patient and provider is critical when initiating opioid therapy. Often providers will need to adjust prescribing practices and motivate patients to stay committed to the changes. During this COCA Call, clinicians will learn how to apply principles of motivational interviewing and a six-step process that is patient-centered and supports clinical judgment when conflict arises. Presenters will review two case studies in which they will apply communication strategies, and provide examples of patient-provider dialogue.

Objectives

• Outline key talking points to communicate to a patient who has been prescribed opioid therapy.
• Provide practical strategies to help motivate a patient’s commitment to opioid therapy adjustment.
• Apply a patient-centered, six-step process to minimize conflict when communicating opioid dosing recommendations.

Call Materials

• Slides: Read Now
• Transcript: Read Now
• Audio: Listen Now
• Webcast: Watch Now

Additional Resources

CDC Guideline for Prescribing Opioids for Chronic Pain and Related Materials

• SAMHSA Buprenorphine Training for Physicians
• MMWR: CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
• JAMA Special Communication: CDC Guideline for Prescribing Opioids for Chronic Pain
• Guideline Resources: Clinical Tools
  • Guideline for Prescribing Opioids for Chronic Pain: Recommendations
  • Checklist for Prescribing Opioids for Chronic Pain
  • Nonopioid Treatments for Chronic Pain
  • Assessing Benefits and Harms of Opioid Therapy
  • Calculating Total Daily Dose of Opioids for Safer Dosage
  • Prescription Drug Monitoring Programs (PDMPs)

CDC Vital Signs

• CDC Vital Signs: Opioid Painkiller Prescribing – Where You Live Makes a Difference

CDC Injury Prevention and Control

• CDC Prescription Drug Overdose
• Prescription Drug Overdose: What Health Care Providers Need to Know about the Epidemic
• Prescription Drug Overdose Prevention for States

Other Agency Resources

• The White House - Office of National Drug Control Policy: Opioid Abuse in the United States[471KB]
• NIH Pain Consortium Centers of Excellence in Pain Education (CoEPEs)
• Providers' Clinical Support System for Medication Assisted Treatment
• Providers' Clinical Support System for Opioid Therapies
• CMS Improvements to Medicare Drug and Health Plans
• SAMHSA - Substance Abuse and Mental Health Services Administration
• National Institute on Drug Abuse
• PDMP Center of Excellence, Brandeis University

Call Format

• Audio conference call on 12/13/16: 2:00 - 3:00 PM EDT
• Web-on-demand training after 3:00 PM EDT on 12/13/16
• Materials: PowerPoint slide set

Accreditation Statements

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU:The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-16-212-L04-P and enduring 0387-0000-16-212-H04-P course category.

Course Category: This activity has been designated as knowledge-based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org.

There is no cost for this program.

DISCLOSURE: CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters, with the exception of Dr. Joseph Merrill and Dr. David Tauben They would like to disclose that their employer, the University of Washington, received a contract payment from the Centers for Disease Control and Prevention. Planners have reviewed content to ensure there is no bias. This presentation will include discussion of the unlabeled use of a product or products under investigational use.